Welcome!

Marketwired .

Subscribe to Marketwired .: eMailAlertsEmail Alerts
Get Marketwired . via: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


News Feed Item

PotNetwork Holding Inc. Strengthens Advisory Board with the Appointment of Distinguished Medical Marijuana Certified Physician

Dr. Michael McKenzie joins Diamond CBD to provide guidance on the development of cannabinoid formulations

FT LAUDERDALE, FL -- (Marketwired) -- 10/12/17 -- PotNetwork Holding Inc. (OTC: POTN) today announces that as part of its strategy to formulate, produce and market a spectrum of exclusive and illness-targeted cannabidiol (CBD) blends, the Company has appointed Dr. Michael McKenzie to the advisory board of its subsidiary, Diamond CBD, Inc.

Diamond CBD is assembling a team of diverse medical professionals with firsthand CBD knowledge and savvy regarding how these components can contribute to optimizing quality of life. As an industry-leading physician, Dr. McKenzie will offer guidance, resources and insight as PotNetwork mobilizes to serve the growing demand for premium medical-grade marijuana products.

"We are amassing a powerful team of professionals with unparalleled knowledge of medicine and the supplementary potential of CBD. We are seeking to be the leading contender in the CBD marketplace and now have the professional credibility for it," states PotNetwork CEO Richard Goulding. "Dr. McKenzie is an incredible asset to our team. He has already provided valuable guidance based on his firsthand knowledge of real patients and experiences of cannabis compounds for the treatment of a wide array of illnesses."

Filling a critical void between traditional pharmaceutical products and the untapped benefits of CBD, Dr. McKenzie has tailored his family practice -- much to the benefit of his wide patient base. His willingness to not accept the status quo has allowed him to be a frontrunner in a bold new medical frontier. His reward has been overwhelming patient acceptance and response.

"The impact of cannabinoid products has greatly improved the quality of life of many of my patients, in ways that I could never have accomplished utilizing pharmacy based products alone," he says. "Being an integral part of this burgeoning new industry allows me an opportunity to enhance my practice and others' even more, with the compounding of products, evaluating dosages and doing what I do best: making lives livable."

Practicing for over 20 years and board certified in family medicine, Dr. McKenzie was determined to include medical marijuana certifications as a part of his practice after witnessing its dramatic successes. "I have personally witnessed the effectiveness of cannabinoid products on hard-to-treat entities, including nausea, pain, inflammatory illnesses, mobility issues, depression, PTSD, and other conditions, and I believe we are just getting started in seeing the potential of cannabis for medical purposes," he says.

Broad, third-party CBD research demonstrates its potential to provide symptomatic relief for a wide range of ailments, including rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy, among numerous reportedly wide-scale healing properties and relieving benefits. Diamond CBD is focused on continuing this research to develop premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives to address these key markets.

Diamond CBD maintains pride and intensity in bringing top-quality hemp-derived products to market. While these consumables are sold as dietary supplements, the Company makes no claim on the potential effects that their proprietary products will have on anyone's individual illness or symptoms.

About Diamond CBD, Inc.
Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD's team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, www.DiamondCBD.com.

About PotNetwork Holding Inc.
PotNetwork Holding Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. For more information, visit www.PotNetworkHolding.com

Safe Harbor Act
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:

PotNetwork Holding Inc.
Marisol Elwell
800.915.3060 Office
Email Contact

NNW Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.